文献速递角膜与眼表疾病

干眼临床试验中安慰剂效应的预测因素:三项临床试验的汇总分析

Predictive factors for the placebo effect in clinical trials for dry eye: a pooled analysis of three clinical trials.
PubMed 文献 · Br J Ophthalmol · 2017-03-18

该汇总分析纳入三项安慰剂对照随机临床试验中分配至安慰剂组的205例干眼患者,采用简单回归和多变量回归分析,评估第4周角膜荧光素染色评分和干眼症状的安慰剂效应预测因素。结果显示,基线评分与相应安慰剂效应显著相关,年龄是FL评分和干眼评分的显著预测因素(p=0.04和p<0.0001);年龄分层分析显示40岁以上患者在FL和干眼评分上更易出现较强安慰剂反应。

要点

  • 基线评分与相应终点的安慰剂效应显著相关
  • 年龄是FL评分(p=0.04)和干眼评分(p<0.0001)安慰剂反应的显著预测因素
  • 40岁以上患者在FL和干眼评分上更易出现较强安慰剂反应

核心结论

  • 基线评分和年龄是干眼临床试验常用终点(如FL评分或干眼症状)安慰剂反应的预测因素
  • 这些患者特征可通过研究设计加以控制,有助于设计统计效能良好的更高效安慰剂对照研究

研究设计与样本

  • 汇总分析三项安慰剂对照随机临床试验中分配至安慰剂组的205例干眼患者
  • 采用简单回归和多变量回归分析,评估第4周角膜荧光素(FL)染色评分和干眼症状
  • 关注变量包括性别、年龄、舍格伦综合征并发症、Schirmer I试验值、泪膜破裂时间和结膜充血评分,并按年龄进行分层分析

主要发现

  • 在所有研究终点中,基线评分与相应安慰剂反应显著相关
  • FL评分和干眼评分中,年龄是安慰剂反应的显著预测因素(p=0.04和p<0.0001)
  • 年龄分层分析显示40岁以上患者在FL和干眼评分上更易出现较强安慰剂反应

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Placebo effect is one of the methodological difficulties in dry eye clinical trials. If we could elucidate the tendencies of the placebo response and find predictors, we could reduce the placebo response in clinical trials for dry eye. In this study, we investigated the predictive factors for the placebo effect in dry eye clinical trials. METHODS: A total of 205 patients with dry eye assigned to the placebo arms of three placebo-controlled randomised clinical trials were analysed by simple and multivariable regression analysis. The corneal fluorescein (FL) staining score and dry eye symptoms were studied at week 4. The variables of interest included gender, age, complications of Sjögren's syndrome, Schirmer's test I value, tear break-up time and conjunctival hyperaemia score. We also conducted a stratified analysis according to the patients' age. RESULTS: Among all the studied endpoints, the baseline scores were significantly related to the corresponding placebo response. In addition, for the FL score and the dryness score, age was a significant predictor of the placebo response (p=0.04 and p<0.0001, respectively). Stratified analysis by age showed that patients more than 40 years of age are more likely to have a stronger placebo response in the FL and dryness scores. CONCLUSION: The baseline scores and age were predictive factors of the placebo response in frequently used endpoints, such as FL score or dryness symptoms. These patient characteristics can be controlled by study design, and our findings enable the design of more efficient placebo-controlled studies with good statistical power.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Imanaka T, Sato I, Tanaka S, et al. Predictive factors for the placebo effect in clinical trials for dry eye: a pooled analysis of three clinical trials. Br J Ophthalmol. 2017. PMID: 28315833. doi:10.1136/bjophthalmol-2016-309887

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。